Shopping Cart
Remove All
Your shopping cart is currently empty
TT-OAD2 is a non-peptide agonist of the glucagon-like peptide-1 (GLP-1) receptor (EC50: 5 nM), with potential for diabetes treatment.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 100 mg | Inquiry | Inquiry | Inquiry | |
| 500 mg | Inquiry | Inquiry | Inquiry |
| Description | TT-OAD2 is a non-peptide agonist of the glucagon-like peptide-1 (GLP-1) receptor (EC50: 5 nM), with potential for diabetes treatment. |
| Targets&IC50 | GLP1 receptor:(EC50)5 nM |
| In vitro | In HEK293A cells, TT-OAD2 (0-10 μM) inhibits GLP-1- and oxyntomodulin-mediated cAMP, calcium, pERK1/2 and β-arrestin responses in a concentration-dependent manner [1]. |
| In vivo | In male human GLP-1 receptor knock-in and knockout mice, TT-OAD2 (3 mg/kg; intravenous injection)treatment induces plasma insulin in an acute IVGTT on humanized GLP-1R knock-in (KI) and GLP-1R knockout (KO) mice[1]. |
| Molecular Weight | 929.75 |
| Formula | C50H49Cl4N3O6 |
| Cas No. | 2382719-60-8 |
| Smiles | CC[C@@H](C1=CC=CC=C1)N2[C@@H](CC3=CC(OC[C@@](C4=CC=C(C=C4)OCC5=CC(Cl)=C(C=C5)Cl)([H])O6)=C6C=C3C2)C(N[C@H](C(O)=O)CC7=CC=C(C8=CC=NC(C)=C8C)C=C7)=O.Cl.Cl |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.